FEDERAL · 21 U.S.C. · Chapter SUBCHAPTER I—CONTROL AND ENFORCEMENT
Judicial review
21 U.S.C. § 877
This text of 21 U.S.C. § 877 (Judicial review) is published on Counsel Stack Legal Research, covering United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
21 U.S.C. § 877.
Text
All final determinations, findings, and conclusions of the Attorney General under this subchapter shall be final and conclusive decisions of the matters involved, except that any person aggrieved by a final decision of the Attorney General may obtain review of the decision in the United States Court of Appeals for the District of Columbia or for the circuit in which his principal place of business is located upon petition filed with the court and delivered to the Attorney General within thirty days after notice of the decision. Findings of fact by the Attorney General, if supported by substantial evidence, shall be conclusive.
Free access — add to your briefcase to read the full text and ask questions with AI
Related
PDK Laboratories Inc. v. United States Drug Enforcement Administration
362 F.3d 786 (D.C. Circuit, 2004)
Barrera-Montenegro v. USA & Drug Enforcement Administration
74 F.3d 657 (Fifth Circuit, 1996)
Morall v. Drug Enforcement Administration
412 F.3d 165 (D.C. Circuit, 2005)
The National Organization for the Reform of Marijuana Laws (Norml) v. John E. Ingersoll
497 F.2d 654 (D.C. Circuit, 1974)
Impact Energy Resources, LLC v. Salazar
693 F.3d 1239 (Tenth Circuit, 2012)
Oregon v. Ashcroft
368 F.3d 1118 (Ninth Circuit, 2004)
Lester Grinspoon, M.D. v. Drug Enforcement Administration
828 F.2d 881 (First Circuit, 1987)
Saeb Mokdad v. Loretta E. Lynch
804 F.3d 807 (Sixth Circuit, 2015)
United States v. Sattar
272 F. Supp. 2d 348 (S.D. New York, 2003)
The National Organization for the Reform of Marijuana Laws (Norml) v. Drug Enforcement Administration, U. S. Department of Justice
559 F.2d 735 (D.C. Circuit, 1977)
Wendy Wagner v. Federal Election Commission
717 F.3d 1007 (D.C. Circuit, 2013)
Masters Pharmaceutical, Inc. v. Drug Enforcement Administration
861 F.3d 206 (D.C. Circuit, 2017)
Reckitt & Colman, Ltd. v. Administrator, Drug Enforcement Administration, McNeil Pharmaceutical, Intervenor
788 F.2d 22 (D.C. Circuit, 1986)
Alliance for Cannabis Therapeutics v. Drug Enforcement Administration
15 F.3d 1131 (D.C. Circuit, 1994)
United States v. Alen Terry White
560 F.2d 787 (Seventh Circuit, 1977)
UNITED STATES OF AMERICA, — v. JACKIE RAE SPRINGER GREGORY M. CHOLLET, —
354 F.3d 772 (Eighth Circuit, 2004)
Jones Total Health Care Pharmacy, LLC v. Drug Enforcement Administration
881 F.3d 823 (Eleventh Circuit, 2018)
Holiday CVS, LLC v. Holder
493 F. App'x 108 (D.C. Circuit, 2012)
United States v. Forrester
592 F.3d 972 (Ninth Circuit, 2010)
Monson v. Drug Enforcement Administration
522 F. Supp. 2d 1188 (D. North Dakota, 2007)
Source Credit
History
(Pub. L. 91–513, title II, §507, Oct. 27, 1970, 84 Stat. 1273.)
Cite This Page — Counsel Stack
Bluebook (online)
21 U.S.C. § 877, Counsel Stack Legal Research, https://law.counselstack.com/usc/21/877.